Johnston C - Search Results

1

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ. Silva IA, et al. Among authors: johnston c. Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498635 Free PMC article.

2

Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer.

Brown JR, Chan DK, Shank JJ, Griffith KA, Fan H, Szulawski R, Yang K, Reynolds RK, Johnston C, McLean K, Uppal S, Liu JR, Cabrera L, Taylor SE, Orr BC, Modugno F, Mehta P, Bregenzer M, Mehta G, Shen H, Coffman LG, Buckanovich RJ. Brown JR, et al. Among authors: johnston c. JCI Insight. 2020 Jun 4;5(11):e133247. doi: 10.1172/jci.insight.133247. JCI Insight. 2020. PMID: 32369446 Free PMC article. Clinical Trial.

3

Adherence to Hematologic Hold Parameters in Carboplatin and Dose-Dense Paclitaxel Chemotherapy for Ovarian Malignancies: A Survey of NCCN Member Institutions.

Stasenko M, Reynolds RK, Johnston C, Brackman M, McLean K, Uppal S. Stasenko M, et al. Among authors: johnston c. J Natl Compr Canc Netw. 2016 Jul;14(7):849-53. doi: 10.6004/jnccn.2016.0089. J Natl Compr Canc Netw. 2016. PMID: 27407125

4

Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.

Greco PS, Bazzi AA, McLean K, Reynolds RK, Spencer RJ, Johnston CM, Liu JR, Uppal S. Greco PS, et al. Obstet Gynecol. 2017 Jun;129(6):979-985. doi: 10.1097/AOG.0000000000001980. Obstet Gynecol. 2017. PMID: 28486358

5

Exponential regression of CA 125 during salvage treatment of ovarian cancer with taxol.

Pearl ML, Yashar CM, Johnston CM, Reynolds RK, Roberts JA. Pearl ML, et al. Among authors: johnston cm. Gynecol Oncol. 1994 Jun;53(3):339-43. doi: 10.1006/gyno.1994.1144. Gynecol Oncol. 1994. PMID: 7911444 Free article. Clinical Trial.

6

Treatment of refractory ovarian carcinoma with paclitaxel and cisplatin after treatment failure with single-agent paclitaxel.

Johnston CM, Pearl ML, Reynolds RK, Roberts JA, Morley GW. Johnston CM, et al. Eur J Gynaecol Oncol. 1995;16(6):439-47. Eur J Gynaecol Oncol. 1995. PMID: 8536758 Clinical Trial.

7

Absence of cumulative bone marrow suppression in heavily pretreated ovarian cancer patients undergoing salvage chemotherapy with paclitaxel.

Pearl ML, Johnston CM, Reynolds RK, Roberts JA. Pearl ML, et al. Among authors: johnston cm. Oncology. 1995 Sep-Oct;52(5):407-12. doi: 10.1159/000227498. Oncology. 1995. PMID: 7543668

8

Perioperative Laboratory Abnormalities in Gynecologic Oncology Surgical Patients.

Burnett TL, Junn J, Kolenic GE, Christen C, Johnston CM, Reynolds RK, McLean K. Burnett TL, et al. Among authors: johnston cm. J Gynecol Surg. 2016 Apr 1;32(2):111-118. doi: 10.1089/gyn.2015.0106. J Gynecol Surg. 2016. PMID: 27041975 Free PMC article.

9

Vulvar melanoma: review of diagnosis, staging, and therapy.

Wechter ME, Reynolds RK, Haefner HK, Lowe L, Gruber SB, Schwartz JL, Johnston CM, Johnson TM. Wechter ME, et al. J Low Genit Tract Dis. 2004 Jan;8(1):58-69. doi: 10.1097/00128360-200401000-00012. J Low Genit Tract Dis. 2004. PMID: 15874838

10

Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer.

Hacker KE, Uppal S, Johnston C. Hacker KE, et al. Among authors: johnston c. J Natl Compr Canc Netw. 2016 Sep;14(9):1175-82. doi: 10.6004/jnccn.2016.0124. J Natl Compr Canc Netw. 2016. PMID: 27587627 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,408 results

Search Page

Filters